Effectiveness of the Fascial Distortion Model in Temporomandibular Disorders: A Randomized Sham-controlled Trial
Launched by KARABUK UNIVERSITY · Oct 3, 2024
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a type of treatment called Manual Therapy based on the Fascial Distortion Model to see how effective it is for people with temporomandibular disorders (TMD), which are conditions that cause pain in the jaw and face. Participants will be divided into two groups: one will receive the actual manual therapy, while the other will receive a sham treatment that doesn't have any therapeutic effect. The researchers will evaluate how this treatment affects things like pain levels, jaw movement, and overall quality of life.
To join the trial, participants must be between the ages of 18 and 75 and have been experiencing TMD symptoms, such as jaw pain, for at least three months. They should also be able to understand and answer questions about their health. However, people with certain health issues, recent surgeries in the jaw area, or those currently receiving other treatments for TMD are not eligible. Participants can expect to undergo some assessments throughout the study to measure the impact of the therapy on their condition while being closely monitored for their well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having temporomandibular joint complaints and being diagnosed with temporomandibular disorder according to the Diagnostic Criteria for Temporomandibular Disorders Axis I
- • Understand and be willing to answer assessment questions
- • A temporomandibular joint complaint for the last three months
- • Pain in the jaw, face or neck
- Exclusion Criteria:
- • Has a systemic disease (neurological, rheumatologic, oncologic, etc.) that may affect the temporomandibular joint, cervical spine and/or assessment
- • Any history of trauma that may have affected the cranio-cervico-facial region
- • Having undergone any surgical intervention in the cranio-cervico-facial region within the last six months
- • Receiving surgical treatment, medical treatment, splint therapy or physiotherapy for temporomandibular disorder in the last month
- • Radiotherapy in the head and neck region
- • Pregnancy or breastfeeding
- • Exercise therapy for craniocervical posture for the last month
About Karabuk University
Karabuk University is a distinguished educational institution located in Turkey, dedicated to advancing scientific research and innovation across various fields, including healthcare. As a clinical trial sponsor, the university plays a pivotal role in facilitating cutting-edge research aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodology, Karabuk University collaborates with healthcare professionals and researchers to design and implement clinical trials that address pressing health challenges, ultimately striving to enhance treatment options and promote public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Merkez, Karabük, Turkey
Merkez, , Turkey
Patients applied
Trial Officials
Harun Gençosmanoğlu, PT, MSc
Principal Investigator
Karabük University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported